A detailed history of Braidwell LP transactions in Celcuity Inc. stock. As of the latest transaction made, Braidwell LP holds 884,306 shares of CELC stock, worth $11 Million. This represents 0.37% of its overall portfolio holdings.

Number of Shares
884,306
Previous 516,643 71.16%
Holding current value
$11 Million
Previous $8.46 Billion 55.8%
% of portfolio
0.37%
Previous 0.27%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$13.98 - $19.15 $5.14 Million - $7.04 Million
367,663 Added 71.16%
884,306 $13.2 Billion
Q2 2024

Aug 14, 2024

BUY
$14.1 - $20.78 $7.28 Million - $10.7 Million
516,643 New
516,643 $8.46 Billion

Others Institutions Holding CELC

About Celcuity Inc.


  • Ticker CELC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 14,941,300
  • Market Cap $186M
  • Description
  • Celcuity Inc., a clinical stage biotechnology company, focuses on the development of molecularly targeted therapies for cancer patients in the United States. The company's CELsignia diagnostic platform uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the related targeted therap...
More about CELC
Track This Portfolio

Track Braidwell LP Portfolio

Follow Braidwell LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Braidwell LP, based on Form 13F filings with the SEC.

News

Stay updated on Braidwell LP with notifications on news.